Hyaluronic acid-coated zein nanoparticle-mediated resveratrol therapy for the reduction of cisplatin-associated nephrotoxicity
Authors:
- 23 October 2024
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 736, 150873
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Hyaluronic Acid Receptor‐Mediated Nanomedicines and Targeted TherapySmall Methods, 2024
- Nanodrugs based on co-delivery strategies to combat cisplatin resistanceJournal of Controlled Release, 2024
- Supramolecular Nano‐Assembly of Caffeate‐Strengthened Phenylboronic Ester with Multistep ROS Scavenging Ability for Targeted Therapy of Acute Kidney InjuryAdvanced Healthcare Materials, 2023
- The underlying mechanisms of cisplatin-induced nephrotoxicity and its therapeutic intervention using natural compoundsNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Zein nanoparticles for drug delivery: Preparation methods and biological applicationsInternational Journal of Pharmaceutics, 2023
- Enzymatic Production of Low-Molecular-Weight Hyaluronan and Its Oligosaccharides: A Review and ProspectsJournal of Agricultural and Food Chemistry, 2022
- A novel zein-selenium complex nanoparticle with controllable size: Quantitative design, physical properties and cytotoxicity in vitroFood Chemistry, 2022
- Hyaluronic acid: A review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studiesInternational Journal of Biological Macromolecules, 2020
- Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney diseaseRedox Biology, 2019
- Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathwayJournal of Molecular Medicine, 2016